A PHASE-II TRIAL OF VP-16-213 IN ADULTS WITH REFRACTORY ACUTE MYELOID-LEUKEMIA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY

被引：52
|
作者：
BENNETT, JM
LYMANN, GH
CASSILETH, PA
GLICK, JH
OKEN, MM
机构：
[1] HOSP UNIV PENN,PHILADELPHIA,PA 19104
[2] SIDNEY FARBER CANC INST,BOSTON,MA 02115
[3] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1984年 / 7卷 / 05期
关键词：
D O I：
10.1097/00000421-198410000-00015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：471 / 473
页数：3
相关论文
共 50 条
  • [31] 5-AZACYTIDINE (NSC-102816) IN REFRACTORY GERM-CELL TUMORS - A PHASE-II TRIAL OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
    ROTH, BJ
    ELSON, P
    SLEDGE, GW
    EINHORN, LH
    TRUMP, DL
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 201 - 202
  • [32] PHASE-II STUDY OF MITOXANTRONE AND CYTARABINE IN ACUTE MYELOID-LEUKEMIA
    BRITOBABAPULLE, F
    CATOVSKY, D
    SLOCOMBE, G
    NEWLAND, AC
    MARCUS, RE
    GOLDMAN, JM
    GALTON, DAG
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 161 - 163
  • [33] PHASE-II STUDY OF MITOXANTRONE AND 5-AZACYTIDINE FOR ACCELERATED AND BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
    DUTCHER, JP
    EUDEY, L
    WIERNIK, PH
    PAIETTA, E
    BENNETT, JM
    ARLIN, Z
    KELLERMEYER, R
    ROWE, J
    OCONNELL, M
    OKEN, M
    CASSILETH, PA
    LEUKEMIA, 1992, 6 (08) : 770 - 775
  • [34] PHASE-II TRIAL OF ORAL VP-16-213 (ETOPOSIDE) IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER
    CRIVELLARI, D
    VERONESI, A
    MAGRI, MD
    TIRELLI, U
    COMORETTO, R
    BARZAN, L
    CARUSO, G
    CARBONE, A
    GRIGOLETTO, E
    TUMORI JOURNAL, 1985, 71 (05): : 499 - 500
  • [35] A PHASE-II STUDY OF ORAL VP-16-213 IN PATIENTS WITH NON-SEMINOMATOUS TESTICULAR CANCER
    CAVALLI, F
    KLEPP, O
    RENARD, J
    HANSEN, HH
    ALBERTO, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 137 - 137
  • [36] AMINOTHIADIAZOLE (NSC =4728) IN PATIENTS WITH ADVANCED COLON CANCER - A PHASE-II STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
    ASBURY, RF
    KRAMAR, A
    HALLER, DG
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (05): : 380 - 382
  • [37] POSTREMISSION THERAPY IN ADULTS WITH ACUTE MYELOGENEOUS LEUKEMIA - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) EXPERIENCE
    ROWE, JM
    ANDERSEN, JW
    CASSILETH, PA
    OKEN, MM
    BENNETT, JM
    WIERNIK, PH
    LEUKEMIA, 1992, 6 : 75 - 77
  • [38] PHASE-II STUDY OF ORAL VP-16-213 IN SMALL-CELL LUNG-CANCER
    MATSUI, Y
    OSHIMA, S
    KADO, M
    NAKAYAMA, M
    SHIMOKATA, K
    SAKAI, S
    ITO, F
    CHIKATA, E
    HARA, K
    KANDA, T
    SHIMA, K
    TAKENAKA, S
    HOKAMA, S
    GENGA, K
    CANCER, 1987, 60 (12) : 2882 - 2885
  • [39] PHASE-II TRIAL OF ETOPOSIDE, DOXORUBICIN, AND CISPLATIN COMBINATION IN ADVANCED MEASURABLE GASTRIC-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
    CLARK, JL
    KUCUK, O
    NEUBERG, DS
    BENSON, AB
    TAYLOR, SG
    PANDYA, KJ
    MANSOUR, EG
    DOUGLASS, HO
    HALLER, DG
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (04): : 318 - 324
  • [40] ACUTE MYELOID-LEUKEMIA TREATED BY AMSACRINE AND CYTOSINE ARABINOSYL - PHASE-II TRIAL
    MARIT, G
    DAVID, B
    REIFFERS, J
    BROUSTET, A
    BULLETIN DU CANCER, 1985, 72 (01) : 37 - 41
12345